Moreover, a nanoassembly, PP-(hDOX&siCD47), formed by DOX-conjugated polyphosphoester and CD47-targeting siRNA, enhances cancer immunotherapy by blocking CD47 and triggering ICD. This evidence concerns the gene CD47 and cancer.